Rauwolscine hydrochloride,
alpha-Yohimbine hydrochloride,
Rauwolscine HCl,
Fauwolscine, hydrochloride,
6211-32-1,
alpha-Yohimbin hydrochloride,
UNII-PQ323MIB24,
EINECS 228-279-6,
NSC 407307,
Rauwolscine (hydrochloride),
PQ323MIB24,
Methyl (16beta,17alpha,20alpha)-17-hydroxyyohimban-16-carboxylate hydrochloride,
20-alpha-Yohimban-16-beta-carboxylic acid, 17-alpha-hydroxy-, methyl ester, hydrochloride,
SMR000718802,
MFCD00069342,
Rauwolscine * HCl,
rauwolscine-hydrochloride,
Isoyohimbine hydrochloride,
Corynanthidine hydrochloride,
AC1L52TT,
MLS001306433,
MLS001333079,
MLS001333080,
MLS002153884,
SCHEMBL178033,
SPECTRUM1503639,
CHEMBL1257131,
CTK8G2906,
HMS1569D16,
Tox21_501093,
CCG-40064,
HY-12710A,
AKOS016012193,
CS-6984,
LP01093,
NCGC00094366-01,
NCGC00094366-02,
NCGC00094366-03,
NCGC00261778-01,
ST056351,
AX8150254,
LS-162746,
B6491,
EU-0101093,
SR-01000597880,
SR-01000075289-2,
SR-01000597880-1,
17alpha-Hydroxy-20alpha-yohimban-16 beta-carboxylic acid methyl ester,
20alpha-Yohimban-16beta-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride,
20alpha-Yohimban-16beta-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride (8CI),
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16beta,17alpha,20alpha)-,
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16beta,17alpha,20alpha)- (9CI),
Antagonil,
alpha-Yohimbine,
|A-Yohimbine hydrochloride,
C21H27ClN2O3,
C21H26N2O3.ClH,
C21-H26-N2-O3.Cl-H,
CID197067,
R-104,
SR-01000075289,
20.alpha.-Yohimban-16.beta.-carboxylic acid, 17.alpha.-hydroxy-, methyl ester, monohydrochloride,
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16.beta.,17.alpha.,20.alpha.)-,